JPRN-UMIN000004810CompletedPhase 1
Phase I/II trial of pemetrexed + carboplatin followed by maintenance pemetrexed therapy in elderly patients with advanced non-small cell lung cancer - CBDCA+PEM followed by PEM in elderly patients (Phase I/II trial)
1:Osaka Prefectural Medical Center for Respiratory and Allergic Diseases 2:Kinki-Chuo chest medical center0 sites50 target enrollmentStarted: December 31, 2010Last updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 75years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1, squamou cell lung cancer 2, Interstitial change in chest X-ray or chest CT, 3, case of uncontrolled fluid 4, not medication of Vitanmin B12 and folic acid 5, Case who has serious renal dysfunction 6, Case of brain metastasis that has symptom 7, Case who has double cancer of briskness 8, case of uncontroled hypertension and diabetic 9, Case diagnosed as cirrhosis 10, Case who has cardiac illness etc
Investigators
Similar Trials
Completed
Phase 2
Phase II study of Pemetrexed + Carboplatin as first line therapy for nonsquamous non-small cell lung cancer with interstitial pneumoniaJPRN-UMIN000011325Central Japan Lung Study Group (CJLSG)25
Completed
Phase 2
Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer without EGFR Mutation (CJLSG0906)JPRN-UMIN000003393Central Japan Lung Study Group53
Completed
Phase 2
Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer with EGFR Mutation (CJLSG0907)JPRN-UMIN000003394Central Japan Lung Study Group23
Completed
Not Applicable
Phase II trial of Pemetrexed and Carboplatin for advanced non-squamous non-small cell lung cancernon-sq NSCLCJPRN-UMIN000002451Kyoto Thoracic Oncology Research Group50
Completed
Phase 2
A Phase II study of Pemetrexed plus Carboplatin followed by maintenance Pemetrexed in patients with previously untreated stage III/IV or post-operative recurrent non-squamous non-small-cell and lung cancer.on-squamous non-small cell lung cancerJPRN-UMIN000003755Dept. of Respiratory Medicine, Osaka University Hospital40